名人面对面

Ram Charan Undergoes Surgery Under His Eyelid_我的网站

A |     BRUSSELS -- A European Union decision on whether to authorize the use of the controversial chemical herbicide glyphosate in the 27-nation bloc for at least 10 more years was delayed for a month after member countries failed to agree on Friday.The chemical, which is widely used in the 27-nation bloc, is approved on the EU market until mid-December. Representatives of the EU’s executive arm and member countries voted Friday in favor of renewing its authorization until 2033, despite protests from environmental groups. But to be adopted, the 10-year extension proposed by the European Commission required a “qualified majority,” defined as 55% of the 27 members representing at least 65% of the total EU population of some 450 million people. Several member states abstained, and that was not achieved. The European Commission is now expected to amend its proposal before another vote takes place next month. Ultimately, if no consensus is found, the Commission will have the final say.Green members of the European Parliament welcomed the delay and urged member states to vote for a complete ban of glyphosate.“It is irresponsible to again renew the authorization of the use of glyphosate,” said Bas Eickhout, the vice-chair of the Parliament's environment committee. "This would give the big agri a blank check to earn billions by selling a pesticide for which there are still big gaps in knowledge about the effects on our health, and at the same time poses large risks for European biodiversity.”Over the past decade, glyphosate, used in products like the weedkiller Roundup, has been at the heart of heated scientific debate about whether it causes cancer and its possible disruptive effect on the environment. The chemical was introduced by Monsanto in 1974 as an effective way of killing weeds while leaving crops and plants intact.The France-based International Agency for Research on Cancer, which is part of the World Health Organization, classified it as a “probable human carcinogen” in 2015. The EU’s food safety agency had paved the way for the 10-year extension when it said in July it “did not identify critical areas of concern” in the use of glyphosate. The U.S. Environmental Protection Agency found in 2020 that the herbicide did not pose a health risk to people, but a federal appeals court in California ordered the agency last year to reexamine that ruling, saying it wasn’t supported by enough evidence.EU member states are responsible for authorizing the use of products including the chemical on their national markets, following a safety evaluation.In France, President Emmanuel Macron had committed to ban glyphosate before 2021 but has since backpedaled. Germany, the EU's biggest economy, plans to stop using it from next year, but the decision could be challenged. Luxembourg’s national ban, for instance, was overturned in court earlier this year.Greenpeace had called on the EU to reject the market reapproval, citing studies indicating that glyphosate may cause cancer and other health problems and could also be toxic to bees. The agroindustry sector, however, claims there are no viable alternatives.“Whatever the final decision that emerges from this re-authorization process, there is one reality that member states will have to face up to,” said Copa-Cogeca, a group representing farmers and agricultural cooperatives. “There is as of yet no equivalent alternative to this herbicide, and without it, many agricultural practices, notably soil conservation, would be rendered complex, leaving farmers with no solutions.”。    It's known that, on Tuesday, actor Ram Charan injured himself on the sets of his upcoming pan-Indian movie, Peddi. Although it was a small injury as per the team, surgery had to be performed to rectify an issue.          Ram Charan goes under the knife     A Hyderabad-based specialist doctor took care of the procedure. The RRR actor has now completely recovered and is set to rejoin the shoot today (March 26). Thanking the doctor, Ram Charan's father and actor, Chiranjeevi, said that it was a "timely and skillful surgery" on his son's eyelid. "It has truly been a blessing. What was a moment of concern for us was eased entirely by your precision, care, and expertise. Your craftsmanship made all the difference, and we are truly grateful," the Megastar wrote on X.          Dr. Sudhakar Prasad garu,Your timely and skilful surgery on Charan’s eyelid has truly been a blessing. What was a moment of concern for us was eased entirely by your precision, care, and expertise.Your craftsmanship made all the difference, and we are truly grateful.Thank… pic.twitter.com/j53rRIpOKB     — Chiranjeevi Konidela (@KChiruTweets) March 26, 2026     From Chiranjeevi's post, it is evident that the incident did worry the family. Since the incident took place in Hyderabad, the Rangasthalam star could promptly consult a specialist at short notice. Earlier, the makers of Peddi gave an update saying that the hero was doing "absolutely fine". They added, "He had a minor injury to the left eye on the sets, and there was a small procedure done."          Peddi likely getting postponed?     According to the latest buzz, Peddi may not hit the screens on April 30. A postponement is likely on the cards, if the industry talk is anything to go by. Earlier today, Prathyangira Cinemas (Peddi's overseas distributor) postponed the rollout of Peddi's advance bookings from March 27 to April 8. It's speculated that this wouldn't have happened had the theatrical release date remained unchanged. Originally, Peddi, directed by Buchi Babu Sana, was earlier supposed to be released on March 26. It was moved to April 30 due to Ranveer Singh-starrer Dhurandhar 2. And now, another postponement will upset Ram Charan's fans. The new date could be May 21, as we await the official confirmation.Also Read:  Ram Charan Sustains Minor Injury on Peddi Film Sets。

Current article:http://lbs.yuejinhuapennuochoudengying.cyou/list_qnm/3hm3o.html

Published on:02:31:44